Skip to main content
Erschienen in: BMC Infectious Diseases 1/2018

Open Access 01.12.2018 | Research article

Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Hanoi, Vietnam

verfasst von: N. B. Hoa, P. D. Phuc, N. T. Hien, V. Q. Hoa, P. H. Thuong, P. T. Anh, N. V. Nhung

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2018

Abstract

Background

Diabetes mellitus (DM) is recognized as an important comorbidity for the development of tuberculosis (TB). With the increase of DM burden globally, concerns have been raised about the emerging co-epidemics of DM and TB, especially in low- and middle-income countries.

Methods

A facility-based, cross-sectional study was carried out in all 30 district TB units in Hanoi, Vietnam. All eligible, diagnosed TB patients aged 15 years old or older were asked to provide consent and were screened for diabetes using fasting blood glucose (FBG). Pre-tested semi-structured questionnaires were used for collecting demographic data, lifestyle habits and clinical data. Identification of pre-diabetes or diabetes in TB patients was done in accordance to parameters set by the American Diabetes Association (2016).

Results

Of 870 eligible TB patients, 831 (95.5%) participated in the study. Of those, 241 (29%; 95%CI: 25.9–32.1%) were prediabetic and 114 (13.7%; 95%CI: 11.4–16.1%) were found to have DM. The risk of DM was higher in patients belonging to the age group 40–64 years (OR 6.09; 95%CI 2.81–13.2); or the age group 65 years or older (OR 2.65; 95%CI 1.65–4.25) or who have a family history of DM (OR 2.71; 95%CI 1.33–5.50).

Conclusions

This study demonstrated high prevalence of DM and prediabetes among TB patients in Hanoi, Vietnam. National Tuberculosis Programme needs to establish a systematic screening process for DM among TB patients.
Abkürzungen
ADA
The American Diabetes Association
BMI
Body Mass Index
CI
Confidence interval
DM
Diabetes Mellitus
EPTB
Extra Pulmonary Tuberculosis
FBG
Fasting blood glucose
IDF
International Diabetes Federation
IFG
Impaired fasting glucose
IQR
Interquartile range
NTP
National Tuberculosis Programme
OR
Odds Ratio
PTB
Pulmonary Tuberculosis;
SD
Standard Deviation
TB
Tuberculosis
UNION
The International Union Against Tuberculosis and Lung Disease
VND
Vietnam Dong
WHO
World Health Organization

Background

Vietnam is a lower middle-income country and ranks 15th amongst the 30 highest Tuberculosis (TB) incidences globally [1]. The World Health Organization (WHO) estimated that there were 126,000 TB incidence cases in Viet Nam in 2016, which accounts for 123 cases per 100,000 population. The number of reported TB cases in Vietnam in 2016 was 106,527 TB cases [1]. The burden of Diabetes mellitus (DM) is increasing worldwide with the International Diabetes Federation (IDF) estimating that approxiately 425 million people are living with diabetes, amounting to 8.8% of the global population [2]. It was also estimated that approximately half of this population was unaware of their DM status in 2016 [2]. Low- and middle-income countries account for approximately 80% of the global DM burden, and more than 90% of the global TB burden [2].
DM is recognized as an important comorbidity for the development of TB, with those who have DM having a two to three times higher risk of developing TB than those without DM [35]. This leads to a higher prevalence rate of TB among DM patients; the rate of DM is also higher among TB patients than in general population [3]. People with TB and DM generally have a poorer response to TB treatments and increased the risk of relapse and death [3, 6, 7]. With the increase of DM burden globally, concerns have been raised about the emerging co-epidemics of DM and TB, especially in low- and middle-income countries.
In 2011, the WHO and the International Union Against Tuberculosis and Lung Disease (the UNION) recommended that TB patients should be routinely screened for DM [3]. The framework recommended all countries should be surveilling diabetes among TB patients [3]. Many studies conducted in different countries have shown the prevalence of DM among TB patients to be approximately 12–44% [8]. Currently, in Vietnam, there is no systematic screening for DM amongst TB patients and limited studies investigating the prevalence of DM amongst TB patients. One study conducted in the National Lung Hospital in 2006–2008 found the prevalence of DM among TB patients to be 8.8% [9].
Hanoi is the capital of Vietnam, has a high proportion of the total TB cases reported in the country. In 2016, Hanoi detected and reported 4382 TB cases, amounting to 59 cases per 100,000 population. This study aimed to identify the prevalence and some associated risk factors of DM amongst TB patients attending district TB units in Hanoi, Vietnam. The results will look to help to establish linkages between TB and DM and provide data to estimate the needs and requirements for DM care services among TB patients in Vietnam.

Methods

Setting and study population

This facility-based, cross-sectional study was conducted in all 30 districts of Hanoi where the total population was estimated at 7,328,400 in 2016. The study population included all TB patients aged over 15 years old, who had been diagnosed and enrolled for TB treatment from October to December of 2016.
The sample size was calculated based on the standard formula for estimating a single population:
$$ n=\frac{Z_{1-\alpha /2}^2\cdot p\cdot \left(1-p\right)}{d^2}\times DE. $$
A previous study conducted in 2006–2008, at the National Lung Hospital in Hanoi, investigated the DM prevalence among 2867 newly diagnosed TB patients and discovered the DM prevalence to be 8.8% [9]. A similar DM prevalence was assumed for this study, with a 95% confidence interval and 20% relative precision. With a cluster sampling of 1.5 the sample size was calculated to be 740 participants. To account for an estimated non-participation rate of 15%, the final sample size required for this study was considered as 870 TB patients.

Sampling method

Patients who were aged 15 years or above and had been diagnosed with TB in any 30 districts of Hanoi were considered for the study. Participants were enrolled for TB treatment between October and December of 2016. Recruitment was continuous until the required sample size was met.

Data collection

All consenting participants were interviewed using pre-tested questionnaires to collect the patient’s information. Questionnaires collected socio-demographic variables including age, sex, weight, height, education, occupation, marital status, average monthly income and HIV status. The questionnaires also collected information around lifestyle factors including smoking, drinking and exercise. The participant’s disease profile and clinical records pertaining to TB and DM status were also collected. TB patients were asked about their DM status. If the TB patients were diagnosed with DM prior to the study, they were not further investigated for the DM, and the patients were requested to provide their most recent DM test results. If the TB patients were did not know or were unsure about their DM status, they were requested to undergo a fasting blood glucose (FBG) test, after the cessation of eating for at least 8 h.

Definition

TB patients’ diagnosis and treatment outcomes were categorized following NTP’s guidelines, which are in line with WHO’s recommendations [10].
Patients with FBG levels ≥126 mg/dl (~ 7 mmol/l) were diagnosed as having DM. Patients with FBG levels between 100 and 126 mg/dl (5.6–6.9 mmol/l) were diagnosed as having impaired fasting glucose (IFG), or prediabetes, in line with guidance from the American Diabetes Association (ADA) [11].
Classification of socioeconomic status was determined following Vietnam Government criteria, issued by Prime Minister for the period 2016–2020 [12]. A “poor” household is one whose per capita income does not exceed 700,000 Vietnam Dong (VND) in rural area and 900,000 VND in urban area. Households are also classified as poor if their per capita income is between 700,000 – 1,000,000 VND in rural areas or 900,000-1,300,000 VND in urban areas when households have unfavourable outcomes in at least three of ten basic social service indicators (access to medical services, health insurance, education level of adults, school attendance of children, housing quality, average housing area per capital, residential water sources, hygienic latrines and toilets, telecom services, and assets to serve information access (TV, computer, radio, other). A “near-poor” household is one whose per capita income is between 700,000–1,000,000 VND or 900,000-1,300,000 VND in rural or urban areas, respectively, and have unfavourable outcomes in at least three of ten basic social service indicators A “medium” household is a household whose per capital income is between 1,000,000–1,500,000 VND in rural area and between 1,300,000-1,950,000 VND in urban area [12].

Statistical analysis

Data was entered into EpiData version 3.1 (EpiData Association, Odense, Denmark) and the analysis were carried out using Stata v.13 software (Stata Corporation, College Station, TX, USA). The main outcomes of the analysis were the number and proportion of TB patients with DM and prediabetes; data was then stratified by sex, age, education, occupation, marital status, residence, monthly incomes, socio-economic status and body mass index (BMI). The proportion of TB patients with DM and prediabetes was also stratified by lifestyle and other factors such as physical activity, smoking, drinking status, family history of DM, type of TB, treatment category and HIV status. Single proportion with 95% confidence interval (CI) was calculated. A Kruskal-Wallis test and Cuzick test were used for the nonparametric data and to test for trend across ordered groups. Odds ratio (OR) with 95% CI were used to describe association between groups. Multivariate logistic regression analysis was performed to calculate adjusted OR for analyzing the association of the related risk factors with the outcome variables.

Ethics approval

The study protocol was approved by the Institutional Review Board of the National Lung Hospital, Hanoi, Vietnam. Patients diagnosed with DM received appropriate treatment. Written informed consent was obtained from each participant prior to enrolment.

Results

A total of 851 eligible TB patients aged ≥15 years old were enrolled during the study period. 831 (97.7%) patients consented and were interviewed.

General characteristics

The socio-demographic characteristics of study’s participants are presented in Table 1. Of 831 TB patients, 549 (66.1%) were males and 282 (33.9%) were females. The mean age of participants was 48.4 (standard deviation (SD): 18.2). More than half of the participants (531, 63.9%) had a secondary or high school education. The number of participants residing in urban areas was 401 (48.3%) and 468 (56.3%) had a monthly income less than 3,000,000 VND. The mean of BMI was 19.6 kg/m2, (SD 3.0) with 34.8% patients was classified as underweight.
Table 1
General characteristics of Tuberculosis patients enrolled for the study, Hanoi, Vietnam, 2016. (n = 831)
General characteristic
n
%
Total
831
100.0
Sex
Male
549
66.1
Female
282
33.9
Age in years
15–24
92
11.1
25–34
133
16.0
35–44
142
17.1
45–54
137
16.5
55–64
175
21.1
65 years and older
152
18.3
Mean age (SD)
48.4 (18.2)
Education
Primary and lower
143
17.2
Secondary; high school
531
63.9
Colleagues/University or higher
157
18.9
Occupation
Unemployed
113
13.6
Farmer
259
31.2
Self-employed
49
5.9
Government employed/ Student; pupil / retired
410
49.3
Marital status
Single
158
19.0
Married
629
75.7
Divorced / separated
44
5.3
Residence
Rural
430
51.7
Urban
401
48.3
Monthly Income (VND)
  < 3,000,000 (~  132.3 US$)
468
56.3
3,000,000 - 5,000,000 (~  132.3–220.5 US$)
220
26.5
  > 5,000,000 (~  220.5 US$)
143
17.2
Socio-economic status
Poor/ near-poor household
103
12.4
Medium household and above
728
87.6
BMI, kg/m2
Underweight, < 18.5
289
34.8
Normal, 18.5–24.9
518
62.3
Overweight, > = 25
24
2.9
Mean (SD)
19.6 (3.0)
*SD Standard deviation; VND Vietnam dong; BMI Body mass index

Prevalence of prediabetes and DM among TB patients

The overall prevalence of prediabetes and DM among TB patients and stratified by general characteristics are shown in Table 2. Of 831 TB patients, 241 (29%; 95% CI: 25.9–32.1%) were prediabetic and 114 (13.7%; 95% CI: 11.4–16.1%)) were found to have DM. The prevalence of DM was higher among males than females (16.0% vs 9.2%) and was shown to increase with age. The incidence of prediabetes was also higher among those in older age groups, those who had primary or lower education levels, those who worked as farmers and in those with a monthly income less than 3,000,000 VND.
Table 2
The prevalence of pre-diabetes and DM among TB patients, in Hanoi, Vietnam, 2016 (n = 831)
 
Total TB patients evaluated for DM (n)
TB patients with pre-DM (n)
Prevalence of pre-DM
(%; 95% CI)
p value*
TB patients with DM (n)
Prevalence of DM (%; 95% CI)
p value*
Total
831
241
29.0 (25.9–32.1)
 
114
13.7 (11.4–16.1)
 
Sex
   
0.274
  
0.007
Male
549
166
30.2 (26.4–34.1)
 
88
16.0 (13.0–19.1)
 
Female
282
75
26.6 (21.4–31.8)
 
26
9.2 (5.8–12.6)
 
Age, years
   
<  0.001
  
<  0.001
15–24
92
19
20.7 (12.2–29.1)
 
5
5.4 (0.7–10.1)
 
25–34
133
23
17.3 (10.8–23.8)
 
6
4.5 (0.9–8.1)
 
35–44
142
37
26.1 (18.7–33.4)
 
16
11.3 (6.0–16.5)
 
45–54
137
47
34.3 (26.3–42.4)
 
27
19.7 (13.0–26.5)
 
55–64
175
61
34.9 (27.7–42.0)
 
33
18.9 (13.0–24.7)
 
  ≥ 65
152
54
35.5 (27.8–43.2)
 
27
17.8 (11.6–23.9)
 
Education
   
0.002
  
0.624
Primary or lower
143
49
34.3 (26.4–42.1)
 
19
13.3 (7.7–18.9)
 
Secondary; high school
531
163
30.7 (26.8–34.6)
 
77
14.5 (11.5–17.5)
 
Colleagues/University or higher
157
29
18.5 (12.3–24.6)
 
18
11.5 (6.4–16.5)
 
Occupation
   
0.002
  
0.328
Unemployed
113
35
31.0 (22.3–39.6)
 
15
13.3 (6.9–19.6)
 
Farmer
259
96
37.1 (31.1–43.0)
 
28
10.8 (7.0–14.6)
 
Self-employed
49
15
30.6 (17.2–44.0)
 
9
18.4 (7.1–29.6)
 
Government employed/ Student; pupil / retired
410
95
23.2 (19.1–27.3)
 
62
15.1 (11.6–18.6)
 
Marital status
   
0.062
  
0.481
Single
158
34
21.5 (15.0–28.0)
 
17
10.8 (5.9–15.6)
 
Married
629
192
30.5 (26.9–34.1)
 
91
14.5 (11.7–17.2)
 
Divorced/separated
44
15
34.1 (19.5–48.7)
 
6
13.6 (3.1–24.2)
 
Residence
   
0.084
  
0.107
Rural
430
136
31.6 (27.2–36.0)
 
51
11.9 (8.8–14.9)
 
Urban
401
105
26.2 (21.9–30.5)
 
63
15.7 (12.1–19.3)
 
Monthly income (VND)
   
<  0.001
  
0.636
  < 3,000,000 (~  132.3 US$)
468
153
32.7 (28.4–37.0)
 
60
12.8 (9.8–15.9)
 
3,000,000 - 5,000,000 (~  132.3–220.5 US$)
220
65
29.5 (23.5–35.6)
 
35
15.9 (11.0–20.8)
 
  > 5,000,000 (~  220.5 US$)
143
23
16.1 (10.0–22.2)
 
19
13.3 (7.7–18.9)
 
Socio-economic status
   
0.794
  
0.790
Poor/ near-poor household
103
31
30.1 (21.1–39.1)
 
15
14.6 (7.6–21.5)
 
Medium household and above
728
210
28.8 (25.5–32.1)
 
99
13.6 (11.1–16.1)
 
BMI, kg/m2
   
0.077
  
0.304
Underweight, < 18.5
289
94
32.5 (27.1–38.0)
 
38
13.1 (9.2–17.1)
 
Normal, 18.5–24.9
518
142
27.4 (23.6–31.3)
 
69
13.3 (10.4–16.3)
 
Overweight, > = 25
24
5
20.8 (3.3–38.4)
 
7
29.2 (9.6–48.8)
 
TB Tuberculosis; DM Diabetes mellitus; CI Confidence interval; SD Standard deviation; VND Vietnam dong; BMI Body mass index
*p value by Kruskal-Wallis test and Cuzick test were used for the nonparametric data and to test for trend across ordered groups

Lifestyle factors

The proportion of DM among TB patients with a family history of DM was 29% (95% CI: 18.0–40.0%) higher than those who did not (12.4, 95% CI: 10.0–14.7%).
The level of pre-diabetes in TB patients who were currently smoking was 34.3% (95% CI: 25.2–43.4%) higher than those never smoked (26.3%; 95% CI: 22.4–33.1%). The proportion of prediabetes was also higher among TB patients with a family history of DM, with the difference nearly reaching the statistical significance (p = 0.052). (Table 3).
Table 3
The prevalence of pre-diabetes and DM among TB patients, stratified by lifestyles and risk factors, in Hanoi, Vietnam, 2016
 
Total TB patients evaluated for DM (n)
TB patients with pre-DM (n)
Prevalence of pre-DM (%; 95% CI)
p value
TB patients with DM (n)
Prevalence of DM (%; 95% CI)
p value
Total
831
241
29.0 (25.9–32.1)
 
114
13.7 (11.4–16.1)
 
Family history of DM
   
0.052
  
<  0.001
Yes
69
13
18.8 (9.4–28.3)
 
20
29.0 (18.0–40.0)
 
No
762
228
29.9 (26.7–33.2)
 
94
12.4 (10.0–14.7)
 
Physical activities
   
0.283
  
0.299
Yes
278
74
26.6 (21.4–31.8)
 
43
15.5 (11.2–19.7)
 
No
553
167
30.2 (26.4–34.0)
 
71
12.8 (10.0–15.6)
 
Frequently of physical activities
   
0.426
  
0.147
  > 4 times per week
168
47
28.0 (21.1–34.8)
 
30
17.9 (12.0–23.7)
 
1–4 times per week
63
16
25.4 (14.3–36.4)
 
9
14.3 (5.4–23.1)
 
1–3 times per month
30
8
26.7 (9.9–43.5)
 
2
6.7 (0–16.1)
 
  < 1 time per month
17
3
17.6 (0.0–37.9)
 
2
11.8 (0–28.8)
 
Smoker
   
0.036
  
0.116
Never smoker
510
134
26.3 (22.4–30.1)
 
61
12.0 (9.1–14.8)
 
Ex-smoker
213
70
32.9 (26.5–39.2)
 
36
16.9 (11.8–22.0)
 
Smoker
108
37
34.3 (25.2–43.4)
 
17
15.7 (8.8–22.7)
 
Drinker
   
0.705
  
0.454
Drinker
374
106
28.3 (23.8–32.9)
 
55
14.7 (11.1–18.3)
 
Non-drinker
457
135
29.5 (25.3–33.7)
 
59
12.9 (9.8–16.0)
 
Type of TB
   
0.219
  
0.070
PTB - smear positive
391
122
31.2 (26.6–35.8)
 
60
15.3 (11.8–18.9)
 
PTB - smear negative
271
68
25.1 (19.9–30.3)
 
40
14.8 (10.5–19.0)
 
EPTB
169
51
30.2 (23.2–37.2)
 
14
8.3 (4.1–12.5)
 
TB treatment category
   
0.138
  
0.815
New
713
200
28.1 (24.7–31.4)
 
97
13.6 (11.1–16.1)
 
Previously treated
118
41
34.7 (26.0–43.5)
 
17
14.4 (8.0–20.8)
 
HIV status
   
0.722
  
0.555
Positive
16
4
25.0 (1.2–48.8)
 
3
18.8 (10.1–40.2)
 
Negative
815
237
29.1 (1.6–26.0)
 
111
13.6 (11.3–16.0)
 
TB Tuberculosis; PTB Pulmonary Tuberculosis; EPTB Extra Pulmonary Tuberculosis; DM Diabetes mellitus;
CI confidence interval; SD Standard deviation; VND Vietnam dong; BM Body mass index
*p value by Kruskal-Wallis test and Cuzick test were used for the nonparametric data and to test for trend across ordered groups

Risk factors associated with DM

In the crude analysis, the associated factors for DM among TB patients were people aged ‘40 years or older’, ‘male’ gender, ‘family members with a history of DM’, ‘pulmonary TB cases’ and a ‘BMI > 25’. After adjusting for other factors in a logistic regression model, the associated factors for DM among TB patients found in this study were age ≥ 40 years and a family history of DM. (Table 4).
Table 4
Factors associated with DM among TB patients, in Hanoi, Vietnam, 2016 (n = 831)
Characteristics
OR (95% CI)
p value
aOR (95% CI)*
p value
Age (years)
  < 40
Reference
   
 40–64
3.56 (2.08–6.07)
< 0.001
6.09 (2.81–13.2)
< 0.001
  ≥ 65
3.42 (1.88–6.23)
< 0.001
2.65 (1.65–4.25)
< 0.001
Sex
 Female
Reference
   
 Male
1.74 (1.15–2.63)
0.007
1.62 (0.96–2.75)
0.071
Family history of DM
 No
Reference
   
 Yes
2.35 (1.55–3.56)
<  0.001
2.71 (1.33–5.50)
0.006
Type of TB
 Extra-pulmonary
Reference
   
 Smear negative
1.78 (1.00–3.17)
0.044
1.26 (0.83–1.91)
0.272
 Smear positive
1.85 (1.07–3.22)
0.024
1.83 (0.86–3.93)
0.119
Smoker
 Never smoke
Reference
   
 Current smoker
1.32 (0.80–2.16)
0.283
0.75 (0.33–1.71)
0.494
 Ex-smoker
1.41 (0.97–2.07)
0.076
0.58 (0.31–1.10)
0.094
BMI
  < 18.5
Reference
   
 18.5–24.9
1.01 (0.70–1.46)
0.945
1.03 (0.65–1.64)
0.885
  > =25
2.22 (1.11–4.42)
0.032
2.27 (0.75–6.82)
0.146
Education
 Primary or lower
Reference
   
 Secondary; high school
1.09 (0.68–1.74)
0.712
1.07 (0.55–2.05)
0.850
 Colleagues/University or higher
0.86 (0.47–1.58)
0.632
0.47 (0.12–1.84)
0.281
TB Tuberculosis; DM Diabetes mellitus; OR Odds ratio; aOR Adjusted odds ratio; CI Confidence interval; BMI Body mass index
*Adjusted for age; sex; residence; education; occupation; marital status; type of TB; family history of DM and BMI in Multivariate logistic regression

Additional yield of DM

Of the 831 screened TB patients, 114 (13.7%; 95% CI: 11.4–16.1%)) were found to have DM, of those, 50 (44%) were newly diagnosed as DM cases. The number of TB patients needed to be screened to diagnose a new DM case was 17, and the number of TB patients needed to carried-out blood testing to diagnose a new DM case was approximately 16. (Table 5).
Table 5
Number of patients needed to screen to find a new DM case among TB patients, in Hanoi, Vietnam, 2016. (n = 831)
Characteristic
Total TB patients evaluated for DM (n)
Number of patients with previous DM (n)
Number of newly diagnosed DM patients (n)
Additional yield (%)
Number needed to screen to diagnose a new case (n)
Total
831
64
50
43.9
17
Sex
Male
549
49
39
44.3
14
Female
282
15
11
42.3
26
Age, years
  < 40
289
4
11
73.3
26
40–65
390
45
27
37.5
14
  ≥ 65
152
15
12
44.4
13
Family history of DM
Yes
69
17
3
15.0
23
No
762
47
47
50.0
16
Type of TB
PTB - smear positive
391
40
20
33.3
20
PTB - smear negative
271
21
19
47.5
14
EPTB
169
3
11
78.6
15
BMI, kg/m2
Underweight, < 18.5
289
19
19
50.0
15
Normal, 18.5–24.9
518
38
31
44.9
17
Overweight, > = 25
24
7
0
0.0
 
TB Tuberculosis; PTB Pulmonary Tuberculosis; EPTB Extra Pulmonary Tuberculosis; DM Diabetes mellitus; BMI Body mass index

Discussion

The prevalence of DM among TB patients in this study was 13.7% (95% CI: 11.4–16.1%), which is much higher than the estimated prevalence of DM among people aged 18–99 in the general population of Vietnam in 2016 (5.34%; 95% CI: 4.32–7.32%) [13]. The prevalence of DM amongst TB patients is also higher than in the previous study in 2006–2008, in Hanoi, Vietnam (8.8%) [9].
This study showed a 29% prevalence rate of prediabetes amongst TB cases in Hanoi. The prevalence of prediabetes among TB cases was slightly higher than study findings from India (24.5%) [14]; and much higher than study findings in Ethiopia (11.5%) [8]; China (7.8%) [15]; India (7%; 8.5%) [5, 16]. This finding may indicate an increased relatively higher prevalence of DM among TB patients in the future in Vietnam.
The prevalence of DM among TB patients in this study (13.7%) is slightly lower than the global median DM prevalence among TB patients, estimated at 16% (IQR 9.0–25.3%) found by Mahteme et.al [17]. This systematic review had analysed 78 studies reporting DM prevalence among TB patients, representing 33 countries globally. The prevalence of DM amongst TB patients ranged from 1.9% in Cotonou-Benin to 45% in the Ebeye-Mashall Islands [18, 19]. Our study results are comparable with the overall median prevalence of DM among TB patients in Asia, estimated to be 17% (IQR 11.4–25.8%). The prevalence of DM among TB patients in Asia ranges from 5.1% in Salury-South India to 44% in Kerala-India. [5, 17, 20].
The associated risk factors for TBDM comorbidity including sex, age, family history of DM, pulmonary form of TB and positive sputum smear were found in many other studies [17]. In this study, all the above-mentioned factors were found to be associated factors in the bivariate analysis. However, after multivariate analysis, adjusted for other variables, only increasing age and family history of DM remained significant for factors associated with TBDM comorbidity.
Our study found that age was a significant risk factors for TB and DM comorbidity, a finding consistent with many other studies [8, 14, 17, 20, 21]. In our study, the risk of having DM was 6 times higher in the 40–65 age group when compared to those patients under 40 years old; the risk dropped to approximately 3 times higher in the age group 65 years old and older when compare to age groups of patients less than 40 years old. This may be explained by the link between increasing age and decreases in immune status, one risk factor for both TB and DM [8].
Having a family history of DM is known as a risk factor for DM [7, 12]. Our study also found the risk of DM is 2.7 times higher among TB patients who had a family history of DM. This finding was consistent with other studies conducted in Ethiopia, China, and India [8, 14, 17, 21].
Many studies have also reported a higher prevalence of DM and prevalence of prediabetes amongst males compared to females [6, 20]. In our study, male TB patients were also identified to have a higher risk of DM in the bivariate analysis. One reasons for this may be a higher frequency of habits such as smoking and drinking alcohol among men. However, the multivariate analysis could not show a significant association.
In this study, 17 TB cases were needed to be screened in order to diagnose one new DM case. This number is high compared to other studies in Ethiopia (20 cases) [8]; Gujarat-India (25 cases) [16]; and South, India (31 cases) [5]. Such a finding suggests that the implementation of a DM screening strategy for TB patients in Hanoi could be high-value.
This study also demonstrated that a high level of participation was possible for DM testing amongst TB patients in Hanoi, Vietnam. In 2011, in the collaboration framework, WHO and the UNION have recommended screening for DM among TB patients [3]. Given the high prevalence of DM, especially the high prevalence of prediabetes among TB patients, Vietnam NTP should collaborate with diabetes programme and establish a systematic screening process for DM among TB patients. This program would enable early diagnosis of DM to be made and reduce morbidity and mortality amongst TB patients.
This study has some limitations. As the study was conducted in an urban area, Hanoi city, the findings may not be representative of the entire country, particularly rural areas. Secondly, the study was only implemented among TB patients who were diagnosed and treated in NTP system, thus it may not be representative of TB patients diagnosed and treated in the private or non-NTP public sectors, or TB patients who have not been diagnosed. Thirdly, decisions on the diagnosis of DM were based on FBG only, this testing methodology may be less sensitive than glycosylated haemoglobin or oral glucose tolerance tests. Finally, this study used the standard cut-off points for BMI categories, it did not use cut-off points specific to Asian populations as recommended by the WHO.

Conclusions

In conclusion, this study illustrated the high prevalence of DM and prediabetes among TB patients in Hanoi, Vietnam. This was especially true for persons aged over 40 years old or who had a family history of DM. Given the high prevalence of DM, particularly the high prevalence of prediabetes among TB patients, this study recommends the Vietnam NTP need to collaborate with diabetes programme to establish a systematic screening process for DM amongst TB patients.

Acknowledgements

We would like to thank the Vietnam NTP, Center for Public Health and Ecosystem Research, Hanoi University of Public Health; Institute of Environmental Health and Sustainable Development study team; and health staff of 30 DTUs in Hanoi and the patients for their kind cooperation and participation in the study.
We thank the Department for International Development (DFID), UK, for funding the Global Operational Research Fellowship Programme in which Nguyen Binh Hoa works as an operational research fellow. La Fondation Veuve Emile Metz-Tesch supported open access publications costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Funding

Not applicable.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
The study protocol was approved by the Institutional Review Board of the National Lung Hospital, Hanoi, Vietnam. Patients diagnosed with DM received appropriate treatment. Written informed consent was obtained from each participant prior to enrolment.
Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat World Health Organization. Global tuberculosis report 2017. World Health Organization Document. WHO/HTM/TB/2017. 2017;23:1–249. World Health Organization. Global tuberculosis report 2017. World Health Organization Document. WHO/HTM/TB/2017. 2017;23:1–249.
3.
Zurück zum Zitat International Union Against Tuberculosis and Lung Disease, World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes. World Health Organization Document. WHO/HTM/TB/2011. 2011;15:1–40. International Union Against Tuberculosis and Lung Disease, World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes. World Health Organization Document. WHO/HTM/TB/2011. 2011;15:1–40.
5.
Zurück zum Zitat Achanta S, Tekumalla RR, Jaju J, et al. Screening tuberculosis patients for diabetes in a tribal area in South India. Public Health Action. 2013;3(suppl 1). Achanta S, Tekumalla RR, Jaju J, et al. Screening tuberculosis patients for diabetes in a tribal area in South India. Public Health Action. 2013;3(suppl 1).
6.
Zurück zum Zitat Shidam UG, Roy G, Sahu SK, Kumar SV, Ananthanarayanan PH. Screening for diabetes among presumptive tuberculosis patients at a tertiary care Centre in Pondicherry, India. Int J Tuberc Lung Dis. 2015;19:1163–8.CrossRef Shidam UG, Roy G, Sahu SK, Kumar SV, Ananthanarayanan PH. Screening for diabetes among presumptive tuberculosis patients at a tertiary care Centre in Pondicherry, India. Int J Tuberc Lung Dis. 2015;19:1163–8.CrossRef
7.
Zurück zum Zitat Viney K, Cavanaugh J, Kienene T, et al. Tuberculosis and diabetes mellitus in the Republic of Kiribati: a case-control study. Tropical Med Int Health. 2015;20:650–7.CrossRef Viney K, Cavanaugh J, Kienene T, et al. Tuberculosis and diabetes mellitus in the Republic of Kiribati: a case-control study. Tropical Med Int Health. 2015;20:650–7.CrossRef
8.
Zurück zum Zitat Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in South-Eastern Amhara region, Ethiopia: a cross sectional study. PLoS One. 2016;11:e0147621.CrossRef Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in South-Eastern Amhara region, Ethiopia: a cross sectional study. PLoS One. 2016;11:e0147621.CrossRef
9.
Zurück zum Zitat Thanh NP, Khue PM, Sy DN, et al. Diabète chez les nouveaux cas de tuberculose pulmonaire à Hanoï, Viet Nam. Bulletin de la Société de pathologie exotique. 2015;108(5):337–41.CrossRef Thanh NP, Khue PM, Sy DN, et al. Diabète chez les nouveaux cas de tuberculose pulmonaire à Hanoï, Viet Nam. Bulletin de la Société de pathologie exotique. 2015;108(5):337–41.CrossRef
10.
Zurück zum Zitat World Health Organization. Definitions and reporting framework for tuberculosis-2013 revision. World Health Organization Document 2013. WHO/HTM/TB. 2013;2:1–40. World Health Organization. Definitions and reporting framework for tuberculosis-2013 revision. World Health Organization Document 2013. WHO/HTM/TB. 2013;2:1–40.
15.
Zurück zum Zitat Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Tropical Med Int Health. 2012;17:1294–301.CrossRef Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Tropical Med Int Health. 2012;17:1294–301.CrossRef
16.
Zurück zum Zitat Dave P, Shah A, Chauhan M, et al. Screening patients with tuberculosis for diabetes mellitus in Gujarat. India Public Health Action. 2013;3(suppl 1):S29–33.CrossRef Dave P, Shah A, Chauhan M, et al. Screening patients with tuberculosis for diabetes mellitus in Gujarat. India Public Health Action. 2013;3(suppl 1):S29–33.CrossRef
17.
Zurück zum Zitat Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: a systematic review. PLoS One. 2017;12:e0175925.CrossRef Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: a systematic review. PLoS One. 2017;12:e0175925.CrossRef
18.
Zurück zum Zitat Ade S, Affolabi D, Agodokpessi G, et al. Low prevalence of diabetes mellitus in patients with tuberculosis in Cotonou, Benin. Public Health Action. 2015;5:147–9.CrossRef Ade S, Affolabi D, Agodokpessi G, et al. Low prevalence of diabetes mellitus in patients with tuberculosis in Cotonou, Benin. Public Health Action. 2015;5:147–9.CrossRef
19.
Zurück zum Zitat Nasa JN, Brostrom R, Ram S, et al. Screening adult tuberculosis patients for diabetes mellitus in Ebeye. Republic of the Marshall Islands Public Health Action. 2014;4(Suppl 1):S50–2.CrossRef Nasa JN, Brostrom R, Ram S, et al. Screening adult tuberculosis patients for diabetes mellitus in Ebeye. Republic of the Marshall Islands Public Health Action. 2014;4(Suppl 1):S50–2.CrossRef
20.
Zurück zum Zitat Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One. 2012;7:e46502.CrossRef Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One. 2012;7:e46502.CrossRef
Metadaten
Titel
Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Hanoi, Vietnam
verfasst von
N. B. Hoa
P. D. Phuc
N. T. Hien
V. Q. Hoa
P. H. Thuong
P. T. Anh
N. V. Nhung
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2018
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3519-5

Weitere Artikel der Ausgabe 1/2018

BMC Infectious Diseases 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.